PedsEndoPhilly said:

Denials are usually procedural rather than clinical, and the order that works reflects that.

PedsEndoPhilly said:

...compounded vs brand cost and coverage...

This debate comes up weekly and I think both sides have valid points:

Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable

Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility

My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.

PedsEndoPhilly said:

Denials are usually procedural rather than clinical, and the order that works reflects that.

This is where I part company with the consensus forming above. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

DebRD_ATL said:

The affordability discussion here usually stops at individual tactics.

Financial impact of cost and coverage weight loss beyond medication cost:

• Groceries: SAVED $253/month (eating less)
• Restaurants: SAVED $223/month (fewer meals out)
• Alcohol: SAVED $173/month (stopped drinking)
• Life insurance: Premium REDUCED by $43/month (lower BMI)
• Copays: SAVED $73/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

COA_Karl said:

PedsEndoPhilly said: ...compounded vs brand cost and coverage...

Can confirm. Same sequence, different timescale.